Company / Operating Cash Flow
NextCure, Inc. Operating Cash Flow History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$45.0M
FY2021
5-year range
-$45.0M / $8.0M
FY2019-FY2021
Trend
-26.2%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $8M to -$45M over the past 2 years.
Based on SEC 10-K filings.
-$45M in FY2021.
Declined from $8M to -$45M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating cash flow decreased 26.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$45.0M | -26.2% |
| FY2020 | -$35.6M | -545.7% |
| FY2019 | $8.0M | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 28, 2026